Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 344.87 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $344.87 | 52 Week High | $89.18 | |||
| Open | $344.87 | 52 Week Low | $65.70 | |||
| Day High | $344.87 | P/E | 160.40 | |||
| Day Low | $344.87 | EPS | $2.15 | |||
| Volume | 247 | |||||
